HC Wainwright & Co. Reiterates Buy on Prothena Corp, Maintains $14 Price Target
Benzinga Newsdesk 1 year ago
NewsPrice TargetReiterationAnalyst Ratings
HC Wainwright & Co. analyst Andrew S. Fein reiterates Prothena Corp (NASDAQ:PRTA) with a Buy and maintains $14 price target.
HC Wainwright & Co. analyst Andrew S. Fein reiterates Prothena Corp (NASDAQ:PRTA) with a Buy and maintains $14 price target.